Liver Transplantation in Primary Sclerosing Cholangitis

ABSTRACT

Primary sclerosing cholangitis (PSC) represents an important indication for liver transplantation. Selection for and timing of liver transplantation is difficult due to the disease course and the frequent occurrence of hepatobiliary malignancies. Pretransplantation screening of malignancies is difficult, but brush cytology of the biliary ducts seems to represent a possibility for early detection of some cholangiocarcinomas. Patient and graft survivals following liver transplantation are good, with 1 year patient survival exceeding 90%. Survival is also satisfactory in patients with early detected or highly limited cholangiocarcinomas. Recurrent PSC represents a particular problem, and affects as many as 20 to 40% in a long-term perspective. Few predictors of recurrent disease have been identified; severe rejections and their treatment may be of importance.

KEYWORDS

Primary sclerosing cholangitis - liver transplantation - cholangiocarcinoma - recurrent disease

REFERENCES

• 1 Adam R, McMaster P, O'Grady J G et al.. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry.  Liver Transpl. 2003;  9 1231-1243
• 2 Nordic Liver Transplant Registry .Annual report 2004. http://Available at: www.scandiatransplant.org Accessed August 1, 2005
• 3 Stieber A C, Marino I R, Iwatsuki S, Starzl T E. Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation.  Int Surg. 1989;  74 1-3
• 4 The Organ Procurement and Transplantation Network .http://Available at: www.OPTN.org/latestData/rptData.asp Accessed December 31, 2004
• 5 Brandsaeter B, Broome U, Isoniemi H et al.. Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list.  Liver Transpl. 2003;  9 961-969
• 6 Brandsaeter B, Friman S, Broomè U et al.. Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries.  Scand J Gastroenterol. 2003;  38 1176-1183
• 7 Boberg K M, Rocca G, Egeland T et al.. Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis.  Hepatology. 2002;  35 652-657
• 8 Kim W R, Poterucha J J, Wiesner R H et al.. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis.  Hepatology. 1999;  29 1643-1648
• 9 Ricci P, Therneau T M, Malinchoc M et al.. A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease.  Hepatology. 1997;  25(3) 672-677
• 10 Fausa O, Schrumpf E, Elgjo K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis.  Semin Liver Dis. 1991;  11 31-39
• 11 Okolicsanyi L, Fabris L, Viaggi S, Carulli N, Podda M, Ricci G. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group.  Eur J Gastroenterol Hepatol. 1996;  8 685-691
• 12 Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan-analysis of 192 cases.  J Gastroenterol. 1997;  32 134-137
• 13 Vera A, Moledina S, Gunson B et al.. Risk factors for recurrence of primary sclerosing cholangitis of liver allograft.  Lancet. 2002;  360 1943-1944
• 14 Vera A, Gunson B K, Ussatoff V et al.. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.  Transplantation. 2003;  75 1983-1988
• 15 Brandsaeter B, Isoniemi H, Broome U et al.. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy.  J Hepatol. 2004;  40 815-822
• 16 Bergquist A, Ekbom A, Olsson R et al.. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.  J Hepatol. 2002;  36 321-327
• 17 Leidenius M, Hockerstedt K, Broome U et al.. Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study.  J Hepatol. 2001;  34 792-798
• 18 Buckles D C, Lindor K D, LaRusso N F, Petrovic L M, Gores G J. In primary sclerosing cholangitis, gallbladder polyps are frequently malignant.  Am J Gastroenterol. 2002;  97 1138-1142
• 19 Mazzaferro V, Regalia E, Doci R et al.. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.  N Engl J Med. 1996;  334 693-699
• 20 Bruix J, Sherman M, Llovet J M et al.. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.  J Hepatol. 2001;  35 421-430
• 21 Frezza E E, Mezghebe H. Gallbladder carcinoma: a 28 year experience.  Int Surg. 1997;  82 295-300
• 22 Ahrendt S A, Pitt H A, Nakeeb A et al.. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.  J Gastrointest Surg. 1999;  3 357-367
• 23 Campbell W L, Ferris J V, Holbert B L, Thaete F L, Baron R L. Biliary tract carcinoma complicating primary sclerosing cholangitis: evaluation with CT, cholangiography, US, and MR imaging.  Radiology. 1998;  207 41-50
• 24 Patt C HM, Thuluvath P JM. Liver transplantation for primary sclerosing cholangitis: screening for biliary malignancy and the role of preemptive transplantation.  Curr Opin Organ Transplant. 2002;  7 129-136
• 25 Layfield L J, Cramer H. Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: report of two cases.  Diagn Cytopathol. 2005;  32 119-124
• 26 Brandsaeter B, Isoniemi H, Broome U et al.. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy.  J Hepatol. 2004;  40 815-822
• 27 De Vreede I, Steers J L, Burch P A et al.. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma.  Liver Transpl. 2000;  6 309-316
• 28 Sudan D, DeRoover A, Chinnakotla S et al.. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma.  Am J Transplant. 2002;  2 774-779
• 29 Meyer C G, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients.  Transplantation. 2000;  69 1633-1637
• 30 Wiesner R H, Porayko M K, Dickson E R et al.. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis.  Hepatology. 1992;  16 1290-1299
• 31 Welsh F K, Wigmore S J. Roux-en-Y choledochojejunostomy is the method of choice for biliary reconstruction in liver transplantation for primary sclerosing cholangitis.  Transplantation. 2004;  77 602-604
• 32 Olsson R, Bjornsson E, Backman L et al.. Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers.  J Hepatol. 1998;  28 426-432
• 33 Wiesner R H. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease.  Best Pract Res Clin Gastroenterol. 2001;  15 667-680
• 34 Tzakis A G, Gordon R D, Shaw Jr B W, Iwatsuki S, Starzl T E. Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era.  Transplantation. 1985;  40 667-671
• 35 Merion R M, Burtch G D, Ham J M, Turcotte J G, Campbell D A. The hepatic artery in liver transplantation.  Transplantation. 1989;  48 438-443
• 36 Goldstein R M, Secrest C L, Klintmalm G B, Husberg B S. Problematic vascular reconstruction in liver transplantation. Part I Arterial.  Surgery. 1990;  107 540-543
• 37 Neuberger J. Incidence, timing, and risk factors for acute and chronic rejection.  Liver Transpl Surg. 1999;  5(suppl 1) 30-36
• 38 Lerut J, Demetris A J, Stieber A C et al.. Intrahepatic bile duct strictures after human orthotopic liver transplantation. Recurrence of primary sclerosing cholangitis or unusual presentation of allograft rejection?.  Transpl Int. 1988;  1 127-130
• 39 Porayko M K, Kondo M, Steers J L. Liver transplantation: late complications of the biliary tract and their management.  Semin Liver Dis. 1995;  15 139-155
• 40 Feller R B, Waugh R C, Selby W S, Dolan P M, Sheil A G, McCaughan G W. Biliary strictures after liver transplantation: clinical picture, correlates and outcomes.  J Gastroenterol Hepatol. 1996;  11 21-25
• 41 Neuberger J. Liver transplantation for cholestatic liver disease.  Curr Treat Options Gastroenterol. 2003;  6 113-121
• 42 Graziadei I W, Wiesner R H, Batts K P et al.. Recurrence of primary sclerosing cholangitis following liver transplantation.  Hepatology. 1999;  29 1050-1056
• 43 Harrison R F, Davies M H, Neuberger J M, Hubscher S G. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis?.  Hepatology. 1994;  20 356-361
• 44 Jeyarajah D R, Netto G J, Lee S P et al.. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?.  Transplantation. 1998;  66 1300-1306
• 45 Khettry U, Keaveny A, Goldar-Najafi A et al.. Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study.  Hum Pathol. 2003;  34 1127-1136
• 46 Kubota T, Thomson A, Clouston A D et al.. Clinicopathologic findings of recurrent primary sclerosing cholangitis after orthotopic liver transplantation.  J Hepatobiliary Pancreat Surg. 1999;  6 377-381
• 47 Kugelmas M, Spiegelman P, Osgood M J et al.. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation.  Liver Transpl. 2003;  9 727-732
• 48 Liden H, Norrby J, Friman S, Olausson M. Liver transplantation for primary sclerosing cholangitis-a single-center experience.  Transpl Int. 2000;  13(S1) 62-64
• 49 MacLean A R, Lilly L, Cohen Z, O'Connor B, McLeod R S. Outcome of patients undergoing liver transplantation for primary sclerosing cholangitis.  Dis Colon Rectum. 2003;  46 1124-1128
• 50 Narumi S, Roberts J P, Emond J C, Lake J, Ascher N L. Liver transplantation for sclerosing cholangitis.  Hepatology. 1995;  22 451-457
• 51 Sheng R, Campbell W L, Zajko A B, Baron R L. Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: evidence of recurrent disease.  AJR Am J Roentgenol. 1996;  166 1109-1113
• 52 Yusoff I F, House A K, De Boer W B et al.. Disease recurrence after liver transplantation in Western Australia.  J Gastroenterol Hepatol. 2002;  17 203-207
• 53 Goss J A, Shackleton C R, Farmer D G et al.. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.  Ann Surg. 1997;  225 472-481
• 54 Brandsaeter B, Schrumpf E, Bentdal O et al.. Recurrent primary sclerosing cholangitis after liver transplantation: A magnetic resonance cholangiography study with analyses of predictive factors.  Liver Transpl. 2005;  11(11) 1361-1369
• 55 Hiroyuki S, Hironori Y, Kiichi T et al.. Application of double-balloon endoscopy for afferent limb lesions of Roux-en-Y surgical anastomoses.  Gastrointest Endosc. 2005;  61(suppl 5) AB238
• 56 Graziadei I W, Wiesner R H, Marotta P J et al.. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.  Hepatology. 1999;  30 1121-1127
• 57 Papatheodoridis G V, Hamilton M, Mistry P K, Davidson B, Rolles K, Burroughs A K. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis.  Gut. 1998;  43 639-644
• 58 Dvorchik I, Subotin M, Demetris A J et al.. Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis.  Hepatology. 2002;  35 380-384
• 59 Haagsma E B, Van Den Berg A P, Kleibeuker J H, Slooff M J, Dijkstra G. Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens.  Aliment Pharmacol Ther. 2003;  18 33-44
• 60 Broome U, Lofberg R, Veress B, Eriksson L S. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.  Hepatology. 1995;  22 1404-1408